Coming up next week is an interview with Dr. O'Connor, co-founder of Underdog Pharmaceuticals. He also previously worked with SENS as the Vice President of Research.
Underdog Pharmaceuticals is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.
We last interviewed Dr. O'Connor about his role with SENS, so it will be interesting to hear about this new project and what he's focusing on for the future. If you have any questions for the interview please let us know in the comments below 
Attached Files
-
OConnor_Matthew-1a-o.jpg 56.79KB
0 downloads
